GRQ — UpHealth Cashflow Statement
0.000.00%
Last trade - 00:00- SG$25.55m
- SG$0.87m
Annual cashflow statement for UpHealth, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.3 | -1.97 | -4.29 | -22.7 | -1.37 |
| Depreciation | |||||
| Non-Cash Items | -3.17 | 0.518 | 1.11 | 16.2 | -5.05 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.73 | -1.08 | 2.81 | -6.83 | 0.728 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.4 | 1.49 | 2.83 | -11.7 | -5.7 |
| Capital Expenditures | -2.61 | -4.44 | -1.73 | -0.439 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.9 | 0.476 | -1.49 | 30.6 | 2.05 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.704 | -3.96 | -3.22 | 30.2 | 2.05 |
| Financing Cash Flow Items | -0.362 | -0.614 | -0.72 | -0.752 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.02 | -1.67 | -0.087 | 4.23 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.22 | -3.6 | -0.815 | 18.7 | 3.58 |